Health ❯ Healthcare ❯ Pharmaceuticals ❯ Weight Loss

GLP-1 Medications

Wearable Data Show People Move Less After Starting GLP‑1 Weight‑Loss Drugs

ENDO 2026 presentations link the activity drop to greater risk of lean muscle loss and call for prescribing structured exercise with GLP‑1 therapy.

MHRA Approves Wegovy Daily Pill for Weight Loss in UK

Penn Study Finds About 30% Lower Breast Cancer Incidence Among Women Prescribed GLP‑1 Drugs

Lilly’s Triple‑Agonist Retatrutide Produces Surgery‑Level Weight Loss in Phase 3 Trial

New Trials Show Daily Pills Can Help Maintain Weight Loss After GLP-1 Injections

Novo Nordisk Lifts Outlook After Wegovy Pill Fuels Q1 Beat

Amazon Rolls Out Nationwide GLP-1 Care Program Through One Medical

GLP-1 Pills Accelerate into U.S. Care with Amazon Rollout and New Evidence on Use and Response

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share

FDA Clears Eli Lilly’s Foundayo Oral GLP-1 for Weight Loss, With U.S. Launch Set for April 6

FDA Clears Lilly’s Foundayo Pill, Escalating GLP-1 Weight-Loss Rivalry

FDA Clears 7.2‑mg Wegovy as India Enters Generic Semaglutide Era

Novo Nordisk Strikes Deal With Hims & Hers to Sell Wegovy and Ozempic, Drops Lawsuit

Novo Nordisk Sues Hims & Hers to Halt Compounded Wegovy Copycats

New Evidence Flags Rapid Weight Regain After Stopping GLP-1 Drugs

Amazon Pharmacy Adds FDA-Approved Wegovy Pill With $25 Copays and Nationwide Delivery

Weight Returns Quickly After Stopping GLP-1 Drugs, Oxford Review Finds

Novo Nordisk Launches Wegovy Weight‑Loss Pill in U.S. at $149 Starter Price

FDA Approves First Oral GLP-1 for Obesity as Novo’s Wegovy Pill Sets January U.S. Launch

Lancet Phase 3 Trial Shows Oral GLP-1 Orforglipron Aids Weight Loss and Diabetes Control